Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis syndrome in patients undergoing radiation therapy: A literature review

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 5, 2013, Pages 506-513

  Vern Gross, Tamara Z ^a   Kowal Vern, Areta ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

Erythema multiforme; Radiotherapy; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

EID: 84914704045     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31825d5835     Document Type: Review

References (113)

1. Pollard JM, Gatti RA. Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys. 2009;74:1323-1331.
2. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39-49. Available at: http://www.ojrd.com/content/5/1/39.
3. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607.
4. Von Hebra F. Exudative erythema multiforme. In: Kaiserliche Akademie der Wissenscaften, eds. Atlas der Hautkrankenheiten. 6: Vienna: Austria; kaiserliche Akademie der Wissenschafte; 1866:55-57, 1866; Vol 1. London: The New Sydenham Society: 285-289.
5. Holzknecht G. Febrile Illness with a generalized exanthem as an X-Ray dermatitis. Archivs Dermatol Syphilol. 1903;66:71-73.
6. Davis J, Pack GT. Erythema multiforme following deep X-ray therapy. Arch Dermatol Syphilol. 1952;66:41-48.
7. Aquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol. 2002;138:1019-1024.
8. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child. 1922;24:526-533.
9. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisa1. Br J Dermatol. 1956;68:355-361.
10. Abe R, Shimizu T, Shibaki A, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol. 2003;162:1515-1520.
11. Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol. 2004;114:1209-1215.
12. Nassif A, Moslehi H, Le Gouvello S, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol. 2004;123:850-855.
13. Chung W-H, Hung S-I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010;59:325-332.
14. ∗1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. 2007;48:1015-1018.
15. Wolkenstein P, Charue D, Laurent P, et al. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol. 1995;131:544-551.
16. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-96.
17. Mesia R, Vilajosana E, Lozano A, et al. Management of cutaneous toxicity and radiation dermatitis in patients with squamous cancer of the head and neck undergoing concurrent treatment with cetuximab and radiotherapy. J Cancer Sci Therapy. 2009;1.
18. Hird AE, Wilson J, Symons S, et al. Radiation recall dermatitis: case report and review of the literature. Curr Oncol. 2008;15:53-62.
19. Aguiar D, Pazo R, Duran I, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neuro-Oncol. 2004;66:345-350.
20. Ahmed I, Reichenberg J, Lucas A, et al. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Intl J Dermatol. 2004;43:67-73.
21. Aydin F, Cokluk C, Senturk N, et al. Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol. 2006;20:588-590.
22. Barbosa LA, Teixeira CR. Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. Am J Health Syst Pharm. 2008;65:1048-1050.
23. Borg MF, Probert JC, Zwi LJ. Is phenytoin contraindicated in patients receiving cranial irradiation? Australas Radiol. 1995;39:42-46.
24. Camartin C, Reinhart WH, Kuhn M. Brain irradiation and phenytoin: a dangerous liaison? Schweiz Rundsch Med Prax. 2003;92:393-396.
25. Chevenet C, Ferrier MC, Reverte M, et al. Erythema multiforme caused by the combination of carbamazepine and cerebral irradiation. Ann Dermatol Venereol. 1992;119:929-931.
26. Cockey GH, Amann ST, Reents SB, et al. Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol. 1996;19:32-34.
27. Delattre J-Y, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology. 1988;38:194-198.
28. Duncan KO, Tigelaar RE, Bolognia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol. 1999;40:493-496.
29. Eralp Y, Aydiner A, Taş F, et al. Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation. Am J Clin Oncol. 2001;24:347-350.
30. Errani A, Reggiani M, Schianchi S, et al. Toxic epidermal necrolysis induced by barbiturates and radiotherapy. Br J Dermatol. 1994;131:586-587.
31. Fernández FA, Pintor E, Quesada R, et al. Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy. Actas Dermosifiliogr. 2007;98:483-485.
32. Fidan E, Fidan M, Ozdemir F, et al. Phenytoin and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenousimmunoglobulin. Med Oncol. 2012;29:686-689.
33. Frangogiannis NG, Boridy I, Mazhar M, et al. Cyclophosphamide in the treatment of toxic epidermal necrolysis. S Med J. 1996;89:1002-1003.
34. Giroud M, Oriol P, Sgro M, et al. Erythema multiforme induced by a combination of phenytoin and cerebral irradiation. Therapie. 1990;45:23-25.
35. Gómez-Criado MS, Ayani I, León-Colombo T, et al. Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk. Rev Neurol. 2004;38:1056-1060.
36. Goyal S, Biswas A, Puri T, et al. Stevens-Johnson syndrome following concurrent phenytoin and holocranial radiotherapy. Acta Oncol. 2010;49:259-260.
37. Hoang-Xuan K, Delattre J-Y, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology. 1990;40:1144-1145.
38. Janinis J, Panagos G, Panousaki A, et al. Stevens-Johnson syndrome and epidermal necrolysis after administration of sodium phenytoin with cranial irradiation. Eur J Cancer. 1993;29 A: 478-479.
39. Kandil AO, Dvorak T, Mignano J, et al. Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report. Radiation Oncol. 2010;5:49-53. Available at: http://www.ro-journal.com/content/5/1/49.
40. Khafaga YM, Jamshed A, Allam AA, et al. Steven-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol. 1999;38:111-116.
41. Levitt MR, Benedict WJ, Barton K, et al. Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. J Burn Care Res. 2007;28:524-529.
42. Mamon HJ, Wen PY, Burns AC, et al. Allergic skin reactions to anticonvulsant medication in patients receiving cranial radiation therapy. Epilepsia. 1999;40:341-344.
43. Metro G, Pino S, Pellegrini D, et al. Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis. Anticancer Res. 2007;27:1167-1169.
44. Micali G, Linthicum K, Han N, et al. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy. 1999;19:223-227.
45. Mishriki YY. The case of the dire desquamation. Stevens-Johnson syndrome. Postgrad Med. 1998;103:187-188.
46. Oner Dincbas F, Yörük S, Demirkesen C, et al. Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment. Onkologie. 2004;27:389-392.
47. Romero Maldonado N, Sendra Tello J, Raboso Garcia-Baquero E, et al. Anticonvulsant hypersensitivity syndrome with fatal outcome. Eur J Dermatol. 2002;12:503-505.
48. Rowe JE, Pina J, Sau P, et al. Toxic epidermal necrolysis associated with diphenylhydantoin and cranial irradiation. Int J Dermatol. 1991;30:747-749.
49. Ruggiero A, Buonuomo PS, Maurizi P, et al. Stevens-Johnson syndrome in children receiving therapy and cranial radiotherapy. J Neurooncol. 2007;85:213-215.
50. Topkan E, Zorlu F, Gürkaynak M. Stevens-Johnson syndrome in patients receiving cranial irradiation and concomitant diphenylhydantoin. Turkish J Cancer. 2002;32:164-171.
51. Trent JT, Bowes LE, Romanelli P, et al. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation. J Cutan Med Surg. 2001;5:475-478.
52. Ucgun R, Metintafl M, Kolsuz M, et al. Toxic epidermal necrolysis associated with phenytoin and cranial irradiation in small-cell lung cancer. Turk Resp J. 2001;2:28-30.
53. Uhlmann E. An unexpected X-ray therapy reaction with the use of a barbiturate derivative. Wochenschrift. 1936;62:216-217.
54. Vincenzi B, Santini D, Grilli C, et al. Complications of therapy in cancer patients: case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole brain radiotherapy in a breast cancer patient. J Clin Oncol. 2004;22:4649-4651.
55. Weltman E, Salvajoli JV. Stevens-Johnson syndrome resulting from whole-brain irradiationand phenytoin. Am J Clin Oncol. 1996;19:431.
56. Yeung CK, Ma SY, Hon C, et al. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital. Acta Derm Venereol. 2003;83:179-182.
57. Astudillo L, Maachi B, Benyoucef A, et al. Stevens-Johnson syndrome after amifostine during radiotherapy. Int J Dermatol. 2004;43:284-285.
58. Demiral AN, Yerebakan Ö, Şimşir V, et al. Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report. Jpn J Clin Oncol. 2002;32:477-479.
59. Duparc A, Delaporte E, Coche B, et al. Amifostine-induced Stevens-Johnson syndrome during radiotherapy. Ann Dermatol Venereol. 2008;135:315-317.
60. Hicsonmez A, Andrieu MN, Akyurek S, et al. In regard to Boccia et al: assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys. 2005;61:1279.
61. Lale Atahan I, Özyar E, Sahin S, et al. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy. Br J Dermatol. 2000;143:1072-1073.
62. Valeyrie-Allanore L, Poulalhon N, Fagot J-P, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol. 2008;87:300-303.
63. Zollo E, Cusano F, Argenone A, et al. A case of Stevens-Johnson syndrome possibly induced by amifostine during radiotherapy. Tumori. 2007;93:634-635.
64. Bloch B. Universelle Generalized dermatitis after X-Ray therapy for cancer of the uterus. Schweiz med Wchnschr. 1925;55:744.
65. Cochran RJ, Wilkin JK. Failure of drug rash to appear in a previously irradiated site. Arch Dermatol. 1981;117:810-811.
66. Epstein P. Serious generalized vessel injury in Werlhof's Disease (ITP) after intensive local X-ray therapy. Strahlentherapie. 1962;21:416-418.
67. Estéve E, Favre A, Martin L. Post-radiotherapy eruption in a patient treated with valproic acid. Rowell's syndrome? Ann Dermatol Venereol. 2002;129:901-903.
68. Fleischer AB, Rosenthal DI, Bernard SA, et al. Skin reactions to radiotherapy-a spectrum resembling erythema multiforme: case report and review of the literature. Cutis. 1992;49:35-39.
69. Greenberg HS, Chandler WF, Diaz RF, et al. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. Neurosurg. 1988;69:500-505.
70. Hafiji J, Orpin S, Roberts C, et al. Radiotherapy: a protective role for toxic epidermal necrolysis. Br J Dermatol. 2010;162:1139-1141.
71. Hopkins HH. Acute disseminated lupus erythematosus. Precipitation by roentgen rays and cure with sulfanilamide. Arch Dermatol Syph. 1941;43:833-835.
72. Howell WR, Knight AL, Scruggs HJ. Stevens-Johnson after radiotherapy. S Med J. 1990;83:681-683.
73. Kanai M, Matsumoto S, Nishimura T, et al. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Ann Oncol. 2010;21:189-190.
74. Maiche A, Teerenhovi L. Stevens-Johnson syndrome in patients receiving radiation therapy. Lancet. 1985;6:45.
75. Maxfield WS, Coleman WP. Cutaneous reactions after radiation therapy-report of seven cases. Am J Roentgenol. 1969;105:636-643.
76. Mayer EG, Poulter CA, Aristizabal SA. Complications of irradiation related to apparent drug potentiation by adriamycin. Int J Radiation Oncol Biol Phys. 1976;1:1179-1188.
77. McDonald JB, Singer JW, Bianco JA. Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. Ann Pharmacotherapy. 1992;26:34-35.
78. Mitra SS, Simcock R. Erlotinib induced skin rash spares skin in previously radiotherapy field. J Clin Oncol. 2006;24:e28-e29.
79. Musio D, Parisi E, Dionisi F, et al. Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases. Jpn J Radiol. 2009;27:103-106.
80. Nakatani K, Matsumoto M, Ue H, et al. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer. Breast Cancer. 2008;15:321-323.
81. Nawalkha PL, Mathur NK, Malhorta YK, et al. Severe erythema multiforme (Stevens-Johnson syndrome) following telecobalt therapy. Br J Radiol. 1972;45:768-769.
82. Pandya AG, Kettler AH, Bruce S. Radiation-induced erythema multiforme. An unusual presentation with elastic tissue phagocytosis. Int J Dermatol. 1989;28:600-602.
83. Pardo-Castello V. Allergic cutaneous eruptions after high voltage roentgen therapy. Arch Dermatol Syphilol. 1936;33:886.
84. Phillips TL, Scott CB, Leibel SA, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Rad Oncol Biol Phys. 1995;33:339-348.
85. Ridgway HB, Miech DJ. Erythema multiforme (Stevens-Johnson syndrome) following deep radiation therapy. Cutis. 1993;51:463-464.
86. Sanz A, Del Valle ML. A man whose scapula was spared a drugassociated rash. CMAJ. 2005;15:745.
87. Sarma N. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermatol. 2009;10:164-167.
88. Segura Huerta AA, Tordero P, Cercós AC, et al. Toxic epidermal necrolysis associated with interluekin-2. Ann Pharmacol. 2002;36:1171-1174.
89. Shelley WB, Shelley ED, Campbell AC, et al. Drug eruptions presenting at sites of prior radiation damage (sunlight and electron beam). J Am Acad Dermatol. 1984;11:53-57.
90. Solberg LA, Wick MR, Bruckman JE. Doxorubicin-enhanced skin reaction after whole-body electron beam irradiation for leukemia cutis. Mayo Clin Proc. 1980;55:711-715.
91. Sommers KR, Kong KM, Bui DT, et al. Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anti-Cancer Drugs. 2003;14:659-662.
92. Schreiner K. Recurrent exanthem with X-ray therapy. Strahlentherapie. 1923;16:389-393.
93. Talamonti MS, Catalano PJ, Vaughn DJ, et al. Eastern Cooperative Oncology Group. Phase I trial of protracted venous infusion fluorouracil with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000;18:3384-3389.
94. Veness MJ, Dwyer PK. Erythema multiforme-like reaction associated with radiotherapy. Australas Radiol. 1996;40:334-337.
95. Wiener JS, Tucker JA Jr, Walther PJ. Interleukin 2-Induced dermatotoxicity resembling toxic epidermal necrolysis. S Med J. 1992;85:656-659.
96. Yoshitake T, Nakamura K, Shioyama Y, et al. Erythema multiforme and Stevens-Johnson syndrome following radiotherapy. Radiat Med. 2007;25:27-30.
97. Arnold HL. Erythema multiforme following deep x-ray therapy. Arch Dermatol Syphilol. 1949;60:143-149.
98. Bray S. A skin eruption caused by X-ray therapy on endocrine glands. Br J Radiol. 1939;12:312-315.
99. Burstein JM. Toxic cutaneous reactions after deep X-ray therapy. Cutis. 1967;3:835-840.
100. Castigliano SG. Dermatoses associated with roentgen therapy. Am J Roentgenol. 1941;46:518-531.
101. Chalmers D. A fatal case of erythema multiforme following deep X-ray therapy. Br J Dermatol. 1959;71:256-260.
102. Dedick AF, Whelan VM. Generalized skin reaction following deep x-ray therapy. Radiology. 1959;72:751-753.
103. Kautzky A. Question of an atypical skin reaction to X-ray therapy. Strahlentherapie. 1937;60:439-443.
104. Maccagno A. Pemphigoid exanthem in a malignant lymphogranuloma subjected to X-ray therapy. Minerva Med. 1941;32:101.
105. Loewe L, Camiel MR. Exanthem complicating neoplastic disease. Am J Roentgenol. 1940;43:587-596.
106. Safai B, Good RA, Day NK. Erythema multiforme: report of two cases and speculation on immune mechanisms involved in the pathogenesis. Clin Immuno Immunopath. 1977;7:379-385.
107. Svensson C. Erythema multiforme in a patient receiving radiation therapy-a case report. Acta Oncol. 1991;30:396-397.
108. Cohen N, Strauss G, Lew R, et al. Should prophylactic anticonvulsants be administered to patients with newly diagnosed cerebral metastasis? A retrospective analysis. J Clin Oncol. 1988;6:1621-1624.
109. Byrne TN, Cascino TC, Posner JB. Brain metastases from melanoma. J Neurooncol. 1983;1:313-317.
110. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology. 2000;54:1886-1893.
111. Boccia R, Anné PR, Bourhis J, et al. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Rad Oncol Biol Phys. 2004;60:302-309.
112. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial on amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339-3345.
113. Bourhis J, Blanchard P, Maillard E, et al. Effect of amifostine on survival among patients treated with radiotherapy: a metaanalysis of individual patient data. J Clin Oncol. 2011;29:2590-2597.